Maternal opioid use during pregnancy and the risk of neonatal opioid withdrawal syndrome in the offspring
Abstract Introduction Neonatal opioid withdrawal syndrome (NOWS) is caused by sudden cessation from in utero exposure to opioids. The indications for opioid use during pregnancy are diverse including medication for opioid use disorder and analgesia. The opioid dose typically depends on the indicatio...
Saved in:
| Main Authors: | Anna Warncke Kristensen, Vibeke Vestermark, Anette Kjærbye‐Thygesen, Maria‐Christina Eckhardt, Ulrik Schiøler Kesmodel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-08-01
|
| Series: | Acta Obstetricia et Gynecologica Scandinavica |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/aogs.14850 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
by: Minna M. Kanervo, et al.
Published: (2023-03-01) -
Mothers with Concurrent Opioid and Cocaine Use and Neonatal Opioid Withdrawal Syndrome
by: Divya Rana, et al.
Published: (2025-07-01) -
Prenatal opioid exposure alters pain perception and increases long-term health risks in infants with neonatal opioid withdrawal syndrome
by: Uppala Radhakrishna, et al.
Published: (2025-04-01) -
A phase I pilot study of a mobile education tool for supporting pregnant women with opioid use disorder
by: Ekaterina Burduli, et al.
Published: (2025-06-01) -
Comparative Study Of Verapamil And Amytriptyline In Acute Opioid Abstinence Syndrome
by: Muhammad Yousuf Salat, et al.
Published: (2015-03-01)